Genetics and genomics of Sjgren's syndrome: Research provides clues to pathogenesis and novel therapies

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 111, Issue 6, 2011, Pages 673-680

  Segal, Barbara M ^a   Nazmul Hossain, Abu N M ^b   Patel, Ketan ^c   Hughes, Pamela ^c   Moser, Kathy L ^d   Rhodus, Nelson L ^c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; GENE EXPRESSION PROFILING; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; GENOMICS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; SALIVA; SJOEGREN SYNDROME;

AUTOIMMUNE DISEASES; GENE EXPRESSION PROFILING; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HUMANS; SALIVA; SJOGREN'S SYNDROME;

EID: 79955890768     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2011.01.040     Document Type: Conference Paper

References (58)

1. M. Ramos-Casals, R. Solans, J. Rosas, M.T. Camps, A. Gil, and J. Del Pino-Montes Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients Medicine 87 2008 210 219
2. R.I. Fox Clinical features, pathogenesis, and treatment of Sjogren's syndrome Curr Opin Rheumatol 8 1996 438 445 (Pubitemid 26393845)
3. A.J. Haugen, E. Peen, B. Hultn, A.C. Johannessen, J.G. Brun, and A.K. Halse Estimation of the prevalence of primary Sjgren's syndrome in two age-different community-based populations using two sets of classification criteria: The Hordaland Health Study Scand J Rheumatol 37 2008 30 34
4. I. Anagnostopoulos, E. Zinzaras, I. Alexiou, A.A. Papathanasiou, E. Davas, and A. Koutroumpas The prevalence of rheumatic diseases in central Greece: A population survey BMC Musculoskelet Disord 11 2010 98
5. C. Helmick, D. Felson, R. Lawrence, S. Gabriel, R. Hirsch, and C.K. Kwoh Estimates of the prevalence of arthritis and other rheumatic conditions in the United States Arthritis Rheum 58 2008 15 25
6. J.D. Reveille The molecular genetics of systemic lupus erythematosus and Sjogren's syndrome Curr Opin Rheumatol 4 1992 644 656
7. C. Vitali, S. Bombardieri, R. Jonsson, H.M. Moutsopoulos, E.L. Alexander, and S.E. Carsons Classification criteria for Sjogren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group Ann Rheum Dis 61 2002 544 548
8. T.E. Daniels Labial salivary gland biopsy in Sjgren's syndrome Assessment as a diagnostic criterion in 362 suspected cases Arthritis Rheum 27 1984 147 156 (Pubitemid 14191019)
9. D.F. Friedman, E.A. Cho, J. Goldman, C.E. Carmack, E.C. Besa, and R.R. Hardy The role of clonal selection in the pathogenesis of an autoreactive human B cell lymphoma J Exp Med 174 1991 525 537
10. L. Mellemkjaer, R.M. Pfeiffer, E.A. Engels, G. Gridley, W. Wheeler, and K. Hemminki Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma Arthritis Rheum 58 2008 657 666 (Pubitemid 351364863)
11. T.M. Chused, S.S. Kassan, G. Opelz, H.M. Moutsopoulos, and P.I. Terasaki Sjogren's syndrome association with DLA-Dw3 N Engl J Med 296 1977 895 897
12. K.H. Fye, P.I. Terasaki, J.P. Michalski, T.E. Daniels, G. Opelz, and N. Talal Relationship of HLA-Dw3 and HLA-B8 to Sjogren's syndrome Arthritis Rheum 21 1978 895 897
13. R. Manthorpe, N. Morling, P. Platz, L.P. Ryder, A. Svejgaard, and M. Thomsen Antigen frequencies in Sjogren's syndrome Differences between the primary and secondary form Scand J Rheumatol 10 1981 337 342
14. F.C. Arnett, R. Goldstein, M. Duvic, and J.D. Reveille Major histocompatibility complex genes in systemic lupus erythematosus, Sjogren's syndrome, and polymyositis Am J Med 85 1988 38 41 (Pubitemid 19020564)
15. J.E. Green, S.H. Hinrichs, J. Vogel, and G. Jay Exocrinopathy resembling Sjgren's syndrome in HTLV-1 tax transgenic mice Nature 341 1989 72 74 (Pubitemid 19220661)
16. K. Koike, K. Moriya, K. Ishibashi, H. Yotsuyanagi, Y. Shintani, and H. Fujie Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes Proc Natl Acad Sci U S A 94 1997 233 236
17. P. Porola, L. Virkki, B.D. Przybyla, M. Laine, T.A. Patterson, and A. Pihakari Androgen deficiency and defective intracrine processing of dehydroepiandrosterone in salivary glands in Sjogren's syndrome J Rheumatol 35 2008 2229 2235
18. M. Laine, P. Porola, L. Udby, L. Kjeldsen, J.B. Cowland, and N. Borregaard Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjogren's syndrome Arthritis Rheum 56 2007 2575 2584 (Pubitemid 47237276)
19. S.T. Valtysdottir, L. Wide, and R. Hallgren Low serum dehydroepiandrosterone sulfate in women with primary Sjogren's syndrome as an isolated sign of impaired HPA axis function J Rheumatol 28 2001 1259 1265 (Pubitemid 32510496)
20. P. Porola, M. Laine, I. Virtanen, R. Pllnen, B.D. Przybyla, and Y.T. Konttinen Androgens and integrins in salivary glands in Sjogren's syndrome J Rheumatol 37 2010 1181 1187
21. L.M. Staudt Gene expression profiling of lymphoid malignancies Annu Rev Med 53 2002 303 318 (Pubitemid 34177883)
22. E.C. Baechler, F.M. Batliwalla, G. Karypis, P.M. Gaffney, W.A. Ortmann, and K.J. Espe Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus Proc Natl Acad Sci U S A 100 2003 2610 2615 (Pubitemid 36297546)
23. F.M. Batliwalla, E.C. Baechler, X. Xiao, W. Li, S. Balasubramanian, and H. Khalili Peripheral blood gene expression profiling in rheumatoid arthritis Genes Immun 6 2005 388 397 (Pubitemid 43090514)
24. E.C. Baechler, F.M. Batliwalla, A.M. Reed, E.J. Peterson, P.M. Gaffney, and K.L. Moser Gene expression profiling in human autoimmunity Immunol Rev 210 2006 120 137
25. X. Feng, H. Wu, J.M. Grossman, P. Hanvivadhanakul, D. FitzGerald, and G.S. Park Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus Arthritis Rheum 54 2006 2952 2962
26. K.A. Kirou, C. Lee, S. George, K. Louca, M.G. Peterson, and M.K. Crow Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease Arthritis Rheum 52 2005 1491 1503 (Pubitemid 40663941)
27. T.O. Hjelmervik, K. Petersen, I. Jonassen, R. Jonsson, and A.I. Bolstad Gene expression profiling of minor salivary glands clearly distinguishes primary Sjgren's syndrome patients from healthy control subjects Arthritis Rheum 52 2005 1534 1544 (Pubitemid 40663945)
28. J.E. Gottenberg, N. Cagnard, C. Lucchesi, F. Letourneur, S. Mistou, and T. Lazure Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjgren's syndrome Proc Natl Acad Sci U S A 103 2006 2770 2775
29. E. Wakamatsu, Y. Nakamura, I. Matsumoto, D. Goto, S. Ito, and A. Tsutsumi DNA microarray analysis of labial salivary glands of patients with Sjogren's syndrome Ann Rheum Dis 66 2007 844 845 (Pubitemid 46846717)
30. S. Hu, J. Wang, J. Meijer, S. Ieong, Y. Xie, and T. Yu Salivary proteomic and genomic biomarkers for primary Sjogren's syndrome Arthritis Rheum 56 2007 3588 3600 (Pubitemid 350100692)
31. V. Devauchelle-Pensec, N. Cagnard, J.O. Pers, P. Youinou, A. Saraux, and G. Chiocchia Gene expression profile in the salivary glands of primary Sjgren's syndrome patients before and after treatment with rituximab Arthritis Rheum 62 2010 2262 2271
32. J.E. Gottenberg Primary Sjogren's syndrome: pathophysiological, clinical and therapeutic advances J Bone Joint Surg Br 76 2009 591 594
33. E.S. Emamian, J.M. Leon, C.J. Lessard, M. Grandits, E.C. Baechler, and P.M. Gaffney Peripheral blood gene expression profiling in Sjogren's syndrome Genes Immun 10 2009 285 296
34. O. Kimoto, J. Sawada, K. Shimoyama, D. Suzuki, S. Nakamura, and H. Hayashi Activation of the interferon pathway in peripheral blood of patients with Sjogren's syndrome J Rheumatol 38 2011 310 316
35. A. Brkic, C.G. van Helden-Meeuwsen, J. van der Merwe, H.A. Drexhage, and M.A. Versnel Interferon type I signature in monoctyes in primary Sjogren's syndrome Arthritis Rheum 62 2010 S796
36. F. Mackay, F. Sierro, S.T. Grey, and T.P. Gordon The BAFF/APRIL system: An important player in systemic rheumatic diseases Curr Directions Autoimmun 8 2005 243 265
37. M. Ittah, C. Micelli-Richard, J. Gottenberg, F. Lavie, T. Lazure, and N. Ba B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjgren's syndrome Arthritis Res Ther 8 2006 R51
38. C. Daridon, J.O. Pers, V. Devauchelle, C. Martins-Carvalho, P. Hutin, and Y.L. Pennec Identification of transitional type II B cells in the salivary glands of patients with Sjogren's syndrome Arthritis Rheum 54 2006 2280 2288 (Pubitemid 44051085)
39. J. Groom, S.L. Kalled, A.H. Cutler, C. Olson, S.A. Woodcock, and P. Schneider Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjgren's syndrome J Clin Invest 109 2002 59 68 (Pubitemid 34052542)
40. N.L. Rhodus Proteins identified by SDS-PAGE in patients with primary and secondary Sjogren's syndrome J Dent Res 68 1989 400 404
41. A.M. Delgado-Vega, M.E. Alarcn-Riquelme, and S.V. Kozyrev Genetic associations in type I interferon related pathways with autoimmunity Arthritis Res Ther 12 2010 S2
42. B.D. Korman, M.I. Alba, J.M. Le, I. Alevizos, J.A. Smith, and N.P. Nikolov Variant form of STAT4 is associated with primary Sjgren's syndrome Genes Immun 9 2008 267 270 (Pubitemid 351584194)
43. K.L. Moser, J.A. Kelley, C.J. Lessard, and J.B. Harley Recent insights into the genetic basis of systemic lupus erythematosus Genes Immun 10 2009 373 379
44. C. Miceli-Richard, E. Comets, P. Loiseau, X. Puechal, E. Hachulla, and X. Mariette Association of an IRF5 gene functional polymorphism with Sjogren's syndrome Arthritis Rheum 56 2007 3989 3994 (Pubitemid 350262326)
45. G. Nordmark, G. Kristjansdottir, E. Theander, S. Appel, P. Eriksson, and L. Vasaitis Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjogren's syndrome Genes Immun 2010 10.1038/gene.2010.44
46. C.M. Horvath STAT proteins and transcriptional responses to extracellular signals Trends Biochem Sci 25 2000 496 502
47. W.T. Watford, B.D. Hissong, J.H. Bream, Y. Kanno, L. Muul, and J.J. O'Shea Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4 Immunol Rev 202 2004 139 156 (Pubitemid 39576910)
48. G. Nordmark, G. Kristjansdottir, E. Theander, P. Eriksson, J.G. Brun, and C. Wang Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjgren's syndrome Genes Immun 10 2009 68 76
49. B.L. Cobb, Y. Fei, R. Jonsson, A.I. Bolstad, J.G. Brun, and M. Rischmueller Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjogren's syndrome Ann Rheum Dis 69 2010 1731 1732
50. X. Mariette Therapeutic potential for B-cell modulation in Sjogren's syndrome R. Glover, Rheumatic Disease Clinics of North America 2008 Elsevier Philadelphia, PA 1025 1033
51. N. Roescher, P.P. Tak, and G.G. Illei Cytokines in Sjogren's syndrome: potential therapeutic targets Ann Rheum Dis 69 2010 945 948
52. C.Q. Nguyen, B.H. Yin HL, J.A. Chiorini, and A.B. Peck IL17: Potential therapeutic target in Sjgren's syndrome using adenovirus-mediated gene transfer Lab Invest 91 2010 54 62
53. G.E. Katsifis, S. Rekka, N.M. Moutsopoulos, S. Pillemer, and S.M. Wahl Systemic and local interleukin-17 and linked cytokines associated with Sjgren's syndrome immunopathogenesis Am J Pathol 175 2009 1167 1177
54. J. Pijpe, J.M. Meijer, H. Bootsma, J.E. van der Wal, F.K.L. Spijkervet, and C. Kallenberg Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjogren's syndrome Arthritis Rheum 60 2009 3251 3256
55. V. Devauchelle-Pensec, Y. Pennec, J. Morvan, J.O. Pers, C. Daridon, and S. Jousse-Joulin Improvement of Sjogren's syndrome after two infusions of rituximab (anti-CD20) Arthritis Rheum 57 2007 310 317 (Pubitemid 47164095)
56. J. Pijpe, G.W. van Imhoff, F.K. Spijkervet, J.L. Roodenburg, G.J. Wolbink, and K. Mansour Rituximab treatment in patients with primary Sjogren's syndrome: An open-label phase II study Arthritis Rheum 52 2005 2740 2750 (Pubitemid 41369102)
57. S. Dass, S.J. Bowman, E.M. Vital, K. Ikeda, C.T. Pease, and J. Hamburger Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study Ann Rheum Dis 67 2008 1541 1544
58. J.M. Meijer, P.M. Meiners, A. Vissink, F.K.L. Spijkervet, W. Abdulahad, and N. Kamminga Effective rituximab treatment in primary Sjogren's syndrome: A randomised, double-blind, placebo-controlled trial Arthritis Rheum 62 2010 960 968